Inference delivers end-to-end biometrics expertise for clinical development, from statistical strategy and regulatory-ready data analysis to writing study reports. With experience in eight product submissions, we understand the demands and efficiencies required for success. Experience and trust matter.
OUR SERVICES
01
BIOSTATISTICS
At the core we are a statistical company. Our expertise is in statistics as it is applied to all phases of drug development. We do it deliberately, efficiently, and with passion.
READ MORE
02
DATA MANAGEMENT
Good inference can only be based on good data, and collecting good data has to be planned properly and executed flawlessly. We provide end-to-end clinical data management services.
READ MORE
03
STATISTICAL PROGRAMMING
Reporting of data to regulatory agencies requires programming of standardized datasets, meaningful and validated outputs and thorough documentation for the reviewers.
READ MORE
04
EPIDEMIOLOGY
We offer our biotech partners a range of epidemiological services supporting drug development processes, regulatory approval, post-marketing studies and health technology assessment.
READ MORE
05
PHARMACOKINETICS
Much of drug development rests on questions about dosing, safety, drug interaction, bridging of formulations and populations, and characterizing the PK profile of the molecule and its metabolites.
READ MORE
06
MEDICAL WRITING
Inference’s medical writers have years of experience in preparing ICH-compliant study documents from protocol to CSRs to integrated documents for submission.
READ MORE
WHY INFERENCE
Inference was founded on the principle that quality biostatistics and data handling are crucial to advancing our client’s objectives. Driven by a desire to alleviate disease, we use our extensive experience in biometrics services to offer a comprehensive approaches to drug development.
Rely on our expert biostatisticians, pharmacokineticists, epidemiologists, clinical data managers, and statistical programmers to deliver solutions that reduce study timelines and increase your clinical success rate, and we are accountable for all deliverables.
I say “partner” because that is my perception of Inference’s fundamental working principle. When they take on a project, no matter how large or small, everyone on the Inference Team operates as though the successful completion of each contracted deliverable is their primary focus and “our” success is their success. – Melton B. Affrime, PharmD, President and Chief Scientific Officer, WCCT Global
GET IN TOUCH
Our priorities have always remained to help companies maximize their chances of a successful regulatory submission.
To discuss more about your requirements. Fill in the form and submit & we shall get in touch with you!